Health 

Division of Dermatology

Adam Friedman, M.D.

Dr. Adam Friedman

Assistant Professor, Department of Medicine (Dermatology)

Assistant Professor, Department of Physiology & Biophysics

 

Professional Interests

Adam Friedman, MD is Director of Dermatologic Research and Associate Residency Program Director at the Unified Division of Dermatology of Albert Einstein College of Medicine. Dr. Friedman is currently investigating novel nanotechnologies that allow for controlled and sustained delivery of a wide spectrum of physiologically and medicinally relevant molecules, with an emphasis on treating infectious diseases, accelerating wound healing, immune modulation, and correcting vascular dysfunction. He holds several patents derived from these investigations, and has published over 60 papers/chapters on both his research as well as a variety of clinical areas in dermatology with an emphasis on emerging medical therapies. Dr. Friedman has presented his research in both national and international forums, and has received awards from multiple organizations such as the American Academy of Dermatology and American Society for Dermatologic Surgery. Recently, he was featured on the online forums DermMatters,Nanotechnology Thought Leaders, and Dermquest.

Dr. Friedman is also committed to resident and medical education. He chaired of the leadership workgroup of the American Academy of Dermatology Resident/Fellows Committee, currently serves on the Sulzberger Committee on Education, and is the Senior Editor of the Dermatology In-Review Online Workshop. Dr. Friedman serves as the Dermatology Expert for healthguru.com, publishes a column on Everyday healthy entitled The Skin You're In and in line with his research interests, as the Vice President of the Nanodermatology Society. 

Dr Friedman is co-founder of the newly formed Einstein Emerging Leaders, a group of young professionals who host events through which they can introduce Einstein to like-minded young professionals and who have an interest in making the world a better place through the support of healthcare and research.

 

Selected Publications

Friedman, A, Han, G, Navati, MH, Chacko, M, Gunther, L, Alfieri, A, Friedman, JM. Sustained Release Nitric Oxide Releasing Nanoparticles: Characterization of a Novel Platform Based on Nitrite Containing Hydrogel/Glass Composites. Nitric Oxide 2008 19(1): 12-20.

Han, G, Zippin, J, Friedman, A. From Bench to Bedside: The Therapeutic Potential of    Nitric Oxide in Dermatology. J Drugs Dermatol.  2009; 8(6): 586-591.

Martinez, L, Han, G, Chacko M, Mihu, MR, Jacobson, M, Gialanella, P, Friedman, A, Nosanchuk, J, Friedman, JM. Antimicrobial and Healing Efficacy of Sustained Release   Nitric Oxide Nanoparticles against Staphylococcus aureus Skin Infections. J Invest. Dermatol. 2009: 129; 2463–2469.

Friedman, A and Friedman, JM. Novel Biomaterials for the Sustained Release of Nitric Oxide: Past, Present, and Future. Expert Opin Drug Deliv. 2009; 6(10): 1113-1122.

Han, G, Tar, M, Dwarakka, K, Friedman, A, Melman, A, Friedman, JM, Davies, KP. Nanoparticles as a Novel Delivery Vehicle for Therapeutics Targeting Erectile Dysfunction.  J Sexu Med. 2010; 7(1 Pt 1):224-33.

Martinez, LM, Mihu, MR, Han, G, Cordero, RJB, Casadevall, A, Friedman, A, Friedman, JM, Nosanchuk, JD. Chitosan Effectively Damages Cryptococcus Neoformans Biofilms. Biomaterials 2010; 31(4): 669-79.

Zippin, J and Friedman A. An Update on Nanotechnology in Cosmetics and Sunscreens.  J Drugs Dermatol. 2009; 8(10): 955-958.

Han, G, Martinez, LM, Mihu, MR, Friedman, A, Friedman, JM, Nosanchuk, J.  Nitric   Oxide Releasing Nanoparticles are Therapeutic for Staphylococcus aureus Abscesses in Murine Model of Infection. PLoS ONE  2009; 4(11): e7804. 

Cabrales, P, Han, G, Roche C, Nacharaju, P, Friedman, A, Friedman, J. Sustained Release Nitric Oxide from Long Lived Circulation Nanoparticles. Free Rad Med. 2010; 49(4):530-8.

Englander, L and Friedman, A. Nitric Oxide Nanoparticle Technology: A Novel Antimicrobial Agent in the Context of Current Treatments for Skin and Soft Tissue   Infections J  Clin Aesth Dermatol. 2010; 3(6): 45-50.

Nasir, A and Friedman, A. Nanotechnology and the Nanodermatology Society. J Drugs Dermatol. 2010; 9(7): 879-882.

Cabrales, P, Han, G, Nacharaju, P, Friedman, AJ, Friedman, JM. Reversal of Hemoglobin-Induced Vasoconstriction with Sustained Release of Nitric Oxide. Am J Physiol Heart Circ Physiol. 2011; 300(1):H49-56.

Nacharaju, P, Friedman, AJ, Friedman, JM, Cabrales, P. Exogenous Nitric Oxide Prevents Collapse during Hemorrhagic Shock. Resuscitation. Published Online 2/21/11.

Friedman, A, Jacobson, M, Mann, R. Extensive Ulcerated Pigmented Nodules. J Am Acad Dermatol.2011; 64(5): 994-996.

Friedman, A, Blecher, K, Sanchez, D, Tuckman-Vernon, C, Gialanella, P, Friedman, JM, Martinez, L, Nosanchuk, J. Susceptibility of Gram Positive and Negative Bacteria to Novel Nitric Oxide-Releasing Nanoparticle Technology. Virulence. 2011; 2(3). Online

Friedman, A, Blecher, K, Schairer, D, Tuckman-Vernon, C, Nacharaju, P, Sanchez, D, Gialanelll, P, Martinez, L, Friedman, J, and Nosanchuk, J. Improved Antimicrobial Efficacy with Nitric Oxide Releasing Nanoparticle Generated S-Nitrosoglutathione. Nitric Oxide. 2011; 25: 381-386.

Schairer, D, Martinez, L, Blecher, K, Chouake, J, Nacharaju, P Gialanella, P, Friedman J, Nosanchuk, J, Friedman, A. Nitric Oxide Nanoparticles: Pre-clinical Utility as a Therapeutic for Intramuscular Abscesses. Virulence 2012; 3(1):1-6.

Blecher, K Martinez, LR, Tuckman-Vernon, C, Nacharaju, P, Schairer, D, Chouake, J, Friedman, JM, Alfieri, A, Guha, C Nosanchuk, JD, Friedman, A. Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomedicine 2012 Mar 6. [Epub ahead of print].

Marcherla, C, Sanchez, DA, Ahmadi, M, Vellozi, EM, Friedman, AJ, Nosanchuk, JD, Martinez, LR. Nitric Oxide Releasing Nanoparticles for the Treatment of Candida albicans Burn Infections. Front. Microbio. 2012;3:193. [Epub 2012 Jun 8.]

Tuckman-Vernon, C, Maier, KE, Chouake, J, Friedman, A, Cabrales, P, Friedman, JM, Nacharaju, P. A Nanoparticle Delivery Vehicle for S-nitroso-N-acetyl cysteine: Sustained Vascular Response. Nitric Oxide. 2012 Jun 15. [Epub ahead of print]

Chouake, J, Schairer, D, Kutner, A, Sanchez, D, Makdisi, J, Blecher-Paz, K, Nacharaju, P, Tuckman-vernon, C, Gialanella, P, Friedman, JM, Nosanchuk, JD, Friedman, A. Nitrosoglutathione Generating Nitric Oxide Nanoparticles as an Improved Strategy for Combating Pseudomonas aeruginosa – Infected Wounds. J Drugs Dermatol. 2012; 11(12):1471-1477.

Friedman, AJ,  Phan, J, Schairer,D,  Champer, J, Qin, M , Pirouz, A, Blecher, K, Oren,A, Modlin, RL, and Kim,J. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a novel targeted therapy for cutaneous pathogens. J Invest. Dermatol. Nov 28[Epub ahead of print]

 

More Information About Dr. Adam Friedman

Division of Dermatology

The Nanodermatology Society

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Contact

Montefiore Medical Center
111 East 210th Street
Bronx, NY 10467

Tel: 718.920.2680
Fax: 718.944.4219
adfriedm@montefiore.org

 
Pubmed Search
Collexis Research Profiles
Einstein Research Profiles (ERP) is one of the innovative technologies to create collaborative bridges within and across the entire bench-to-bedside-to-population spectrum of research. The ERP website has been developed in partnership with Collexis to give investigators easy access to PubMed publications, coauthor networks, information about NIH grants, and research networks.

Media Coverage

Good Housekeeping interviews Dr. Adam Friedman about nutrients in food that slow the skin’s aging process and protect against UV damage, including vitamin C, lean protein, fatty fish and beta-carotene.

WABC-TV interviews Dr. Adam Friedman about the importance of applying sun block frequently - and before going outside - to protect skin from sun exposure.

More media coverage

 
Click here to log in